The long-term success of national efforts to reduce breast cancer incidence and mortality rests in part on the ability of Breast Cancer SPORE programs to attract and build the translational research careers of talented young faculty and to redirect senior faculty to breast cancer research. For the past fourteen years, the UNC Breast Cancer SPORE has effectively used career development funds to promote the breast cancer research careers of selected investigators. Participants in the SPORE career development program (CDP) have contributed to the national breast cancer effort and established long-term careers as translational breast cancer researchers. Their contributions include published research, funded grants focused on breast cancer, participation in collaborative breast cancer research and leadership within the SPORE program itself. CDP participants have become an integral part of the UNC Breast Cancer SPORE. Seven CDP alumni (Drs. Carey, Dees, Klauber-DeMore, Livasy, Millikan, Perou Sartor) serve as co-leaders on the projects and core facilities in this application;each of the five proposed SPORE projects has a CDP alum as co-leader. As a result of the Breast Cancer SPORE, all seven investigators are now firmly established as translational breast cancer researchers, each with distinct interests, collaborations, and honors. Over the next five years, the UNC Breast Cancer SPORE will continue to promote and develop careers in translational breast cancer research. We request SPORE support of $50,000 per year to combine with $50,000 in institutional funds to provide $100,000 total in flexible funds for career development. The SPORE will use these funds in three categories: 1) to help recruit and develop junior faculty with translational breast cancer research programs;2) to provide salary support for senior faculty at UNC developing breast cancer research interests or projects;and 3) to attract more senior faculty from other institutions by offering funded leaves of three to twelve months to develop or enhance a breast cancer research focus. For Year 15, the SPORE proposes to support the development of two junior faculty interested in translational breast cancer research: Pilar Blancafort, PhD and Jeffrey Peppercorn, MD. CDP candidates will take advantage of the research and training opportunities available at UNC through the SPORE, the Cancer Center, and the University at large. Working with pre-, postdoctoral, and faculty training programs in the clinical, basic and population sciences, the UNC Breast Cancer SPORE offers unique development opportunities. Fellows and junior faculty can obtain world-class mentoring to fine tune career directions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA058223-18
Application #
8135450
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
18
Fiscal Year
2010
Total Cost
$70,516
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Wheeler, Stephanie B; Spencer, Jennifer C; Pinheiro, Laura C et al. (2018) Financial Impact of Breast Cancer in Black Versus White Women. J Clin Oncol 36:1695-1701
Hong, Chi-Chen; Sucheston-Campbell, Lara E; Liu, Song et al. (2018) Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 27:321-330
Tanioka, Maki; Mott, Kevin R; Hollern, Daniel P et al. (2018) Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer. Genome Med 10:86
Tanioka, Maki; Fan, Cheng; Parker, Joel S et al. (2018) Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Clin Cancer Res 24:5292-5304
Mundt, Filip; Rajput, Sandeep; Li, Shunqiang et al. (2018) Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers. Cancer Res 78:2732-2746
Takaku, Motoki; Grimm, Sara A; Roberts, John D et al. (2018) GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network. Nat Commun 9:1059
Butler, Eboneé N; Bensen, Jeannette T; Chen, Mengjie et al. (2018) Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors. Cancer Epidemiol Biomarkers Prev 27:67-74
Echavarria, Isabel; López-Tarruella, Sara; Picornell, Antoni et al. (2018) Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification. Clin Cancer Res 24:1845-1852
Cai, Ling; Tsai, Yi-Hsuan; Wang, Ping et al. (2018) ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Mol Cell 72:341-354.e6
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45

Showing the most recent 10 out of 598 publications